Regarding the withdrawal from the PET bottle business NEW
Mitsubishi Chemical Corporation (Headquarters: Chiyoda-ku, Tokyo, President: Manabu Chikubo, hereafter "the Company") has decided to withdraw from the PET bottle business as follows. 1. Background of the business withdrawal The Company's PET bottle business has a lineup of products that respond to various needs, primarily for Condiments and Arko Corp. However, due to the recent surge in raw material prices and logistics costs, the business's profitability has become extremely challenging. The Company aims to restructure the business, including reducing fixed costs.
Mitsubishi Chemical Group: Extraordinary Report
Regarding the gradual cessation of product production at Mitsubishi Chemical's Onahama Plant and Shinryo Iwaki Plant NEW.
Mitsubishi Chemical Group (hereafter "our group") has decided to gradually cease production of products at the Mitsubishi Chemical Corporation Onahama Plant and Shinryo Iwaki Corporation (both located in Iwaki City, Fukushima Prefecture) by the end of March 2027. Background of Production Cessation The Mitsubishi Chemical Onahama Plant began operations in September 1937 as Japan Hydrogen Industry Co., Ltd. (later Japan Chemicals Co., Ltd.). In October 2020, Mitsubishi Chemical...
Dai Nippon Printing, Iwatani Industry, ETC [List of brand materials from the newspaper]
*Dai Nippon Printing <7912> expands medical Logistics, opening a base in Tokyo next month (Nikkan Kogyo 1st page) -○*Toho Gas <9533> invests 240 billion yen in Electricity and Overseas over three years, aiming for a recurring profit of 30 billion yen in 2027 (Nikkan Kogyo 4th page) -○*Rohm <6963> jointly develops electric vehicle Components with MAZDA MOTOR CRP, using GaN power Semiconductors (Nikkan Kogyo 11th page) -○*Morita HD <6455> supports firefighting operations with AI, proposing at the Osaka Expo (Nikkan Kogyo 11th page) -○*Sodick <6143> Metal molding machine's Italy.
Mitsubishi Chemical Group To Go Ex-Dividend On March 28th, 2025 With 16 JPY Dividend Per Share
March 27th (Japan Standard Time) - $Mitsubishi Chemical Group(4188.JP)$ is trading ex-dividend on March 28th, 2025.Shareholders of record on March 31st, 2025 will receive 16 JPY dividend per share.
Regarding the conclusion of a licensing agreement for N-vinylformamide manufacturing technology NEW.
Mitsubishi Chemical Group (hereinafter referred to as "the Company Group") and SNF Group (headquartered in France, CEO: Pascal Remy, hereinafter referred to as "SNF") have entered into a licensing agreement regarding the manufacturing technology of N-vinylformamide (NVF), which is a raw material for functional polymer materials held by the company. SNF plans to start commercial operations using the manufacturing technology based on this agreement from June 2025 at a newly constructed plant in Dunkirk, France.
【Mitsubishi Tanabe Pharma】A treatment drug for chronic disease "obesity" caused by multiple factors, a sustained GIP/GLP-1 receptor agonist "Zepbound" Announcements of individual stocks on the price standard listing and release date NEW
Eli Lilly and Co Japan (Headquarters: Kobe City, Hyogo Prefecture, Representative Director: Simone Thomsen, hereafter referred to as Eli Lilly) and Tanabe Mitsubishi Pharma Corporation (Headquarters: Osaka City, Osaka Prefecture, Representative Director: Akihiro Tsujimura, hereafter referred to as Tanabe Mitsubishi Pharma) have announced today, March 1, the long-acting GIP/GLP-1 receptor agonist "Zepbound subcutaneous injection 2.5mg/5mg/7.5mg/10mg/12.5mg/15mg Atheos" (generic name: Chiruza peptide, hereafter referred to as Zepbound).
Mitsubishi Chemical Group's high rigidity and lightweight aerospace components contributed to the successful lunar imaging and data transmission of the lunar rover YAOKI.
The lunar rover YAOKI, made from aerospace materials of the Mitsubishi Chemical Group (hereinafter referred to as "our group"), successfully arrived on the lunar surface in the early hours of March 7, 2025, Japan time, and successfully transmitted image data back to Earth. Developed by the robotics and space development venture Dai Mon, YAOKI is a private project in which our group is also participating, and it became Japan's first lunar rover to operate on the lunar surface. The images taken by YAOKI, top left.
[Mitsubishi Tanabe Pharma] Application for approval of the ALS treatment drug Edaravone oral suspension MT-1186 in South Korea NEW.
Mitsubishi Chemical Group's Tanabe Mitsubishi Pharma Corporation (headquartered in Chuo-ku, Osaka City, representative director: Akihiro Tsujimura, hereinafter referred to as "Tanabe Mitsubishi Pharma") announces that our consolidated subsidiary Mitsubishi Tanabe Pharma Korea Co., Ltd. has received approval for the oral suspension of edaravone (MT-1186) for the indication of amyotrophic lateral sclerosis (ALS).
List of cloud break stocks (Part 2) [Ichimoku Kinko Hyo - List of cloud break stocks]
○ List of stocks below the cloud market Code Stock Name Closing Price Leading Span A Leading Span B Tokyo Stock Exchange Main Board <1801> Taisei Corporation 6451 6460.5 6574.5 <1941> Chudenko 31203221.25 3275 <1968> Taihei Electric 472548504950 <2153> Eiji HD 16161632.5 167.5 <2220> Kameda Confectionery 395039654010 <2
Mirait One, RIKEN Keiki, ETC.
*Mirait One <1417> collaborates with Sumitomo Mitsui Finance & Lease for the preliminary development of solar power at 0.07 million kW (Nikkan Kogyo, front page) - ○ *Riken Keiki <7734> inspects gas detectors in disaster areas and manufactures maintenance vehicles (Nikkan Kogyo, front page) - ○ *MOL <9104> acquires a Dutch company, establishing a land base for Chemical ships (Nikkan Kogyo, page 3) - ○ *Toyota Motor <7203> suspends operations at 3 factories and 4 lines until this morning due to an explosion incident at Central Spring (Nikkan Kogyo, page 3) - ○ *Mitsui & Co. <8031> a major trading company, iron ore.
List of convertible stocks (Part 1) [List of Parabolic Signal convertible stocks]
○ List of stocks converted to Buy in the market Code Stock Name Closing Price SAR Tokyo Main Board <1377> Sakata Seed 3450 3385 <1762> Takamatsu G 27812660 <1815> Tekken 26012491 <1882> Toa Road 15281457 <1887> Japan National Land Development 492478 <1893> Goyo Construction 698631 <1899> Fukuda Group 52604960 <1944> Kindan 33143
The Global Impact Coalition has launched a project for the recycling of plastics from used autos in Europe, aiming to achieve a low-carbon society - a world-first demonstration test conducted jointly by seven global chemical manufacturers, among others -
The Mitsubishi Chemical Group (hereinafter referred to as "our group") announces that the Global Impact Coalition (hereinafter referred to as "GIC"), of which our group is the only member in Japan and aims to achieve low carbon, will start a demonstration project for building a supply chain for plastic recycling of used Autos from February 2025. This project is part of the Chemicals and recycling industry.
【Mitsubishi Tanabe Pharma】 - March 4 is "World Obesity Day" - Project to promote correct understanding of "Obesity" and "Obesity Disorders" - The "Correct Understanding of Obesity and Obesity Disorders Training" begins - Aiming to dispel misunderstandings
Eli Lilly and Co. Japan (Headquarters: Kobe City, Hyogo Prefecture, Representative Director: Simone Thomsen, hereinafter referred to as Eli Lilly Japan) and Tanabe Mitsubishi Pharmaceutical Co. (Headquarters: Osaka City, Osaka Prefecture, Representative Director: Akihiro Tsujimura, hereinafter referred to as Tanabe Mitsubishi) conducted the "Correct Understanding of Obesity and Obesity Disorders Training" at Eli Lilly Japan's Kobe headquarters on March 4th (Tuesday), which is "World Obesity Day," aimed at promoting the correct understanding of "obesity disorders." This training will be developed as corporate training content in the future.
To build a resource-recycling model for cosmetic containers, collaboration with Albione has begun NEW.
Mitsubishi Chemical Group*1 (hereinafter referred to as "the Group") will begin collaboration with Albion Co., Ltd. (hereinafter referred to as "Albion"), which manufactures and sells high-end Cosmetics, aiming to build a resource-circulating model for cosmetic containers. Waste materials generated at Albion will be chemically recycled*2 by the Group and regenerated into new cosmetic containers. Cosmetic containers are delivered to Albion by container manufacturers with plastic cushioning materials to prevent scratches and to avoid dust contamination.
[Tanabe Mitsubishi Pharma] Obtained approval for the additional efficacy of 'Cariprazine' (MP-214), a treatment for schizophrenia and bipolar disorder, as an adjunctive therapy for major depressive disorder in Thailand NEW
Mitsubishi Chemical Group's Tanabe Mitsubishi Pharma Corporation (headquarters: Chuo Ward, Osaka City, Representative Director: Akihiro Tsujimura, hereinafter referred to as "Tanabe Mitsubishi Pharma") announced that its consolidated subsidiary, Mitsubishi Tanabe Pharma (Thailand) Co., Ltd., regarding Cariprazine (generic name, clinical trial code: MP-214, dopamine D3/D2 receptor partial agonist, Thai product name: Reagila) in Thailand.
【Mitsubishi Tanabe Pharma】 Announcement of awareness survey results for obese patients, doctors, and the general public - About 70% of the general public and nearly 90% of obese patients believe that "obesity is self-responsibility." Among them, about two
87% of obesity patients, 64% of doctors, and 70% of the general public answered that obesity is "the individual's responsibility." It was observed that 34% of obesity patients and 41% of the general public, despite being presented with scientific evidence stating that "obesity and obesity-related conditions arise from multiple factors," do not "agree" that it is "difficult to solve solely through one’s own efforts." 78% of obesity patients, 87% of doctors, and 69% of the general public believe that the treatment of obesity should be considered equivalent to or even more important than the treatment of other diseases.
Plant-derived Resin prepreg has obtained ISCC PLUS certification ~ Contributing to reducing environmental impact from sports, Leisure, mobility to industrial applications ~ NEW
Mitsubishi Chemical Group (hereinafter referred to as "the Group") announces that in November 2024, the prepreg made from plant-based Resin manufactured at the Mitsubishi Chemical Tokai Plant (Aichi area) has obtained the ISCC (International Sustainability and Carbon Certification) PLUS certification, which is one of the international certification systems for sustainable products.
[Mitsubishi Tanabe Pharma] The approval application for the Parkinson's disease treatment candidate ND0612 has been accepted by the European Index (EMA) NEW.
Mitsubishi Chemical Group's Tanabe Mitsubishi Pharma Corporation (Headquarters: Chuo-ku, Osaka, Representative Director: Akihiro Tsujimura, hereinafter referred to as "Tanabe Mitsubishi Pharma") received notification on February 20 (local time) that the European Medicines Agency (EMA) accepted the application for marketing authorization for ND0612, which is being developed as a treatment candidate for Parkinson's disease with diurnal variability of motor symptoms. ND0612 is a wholly owned subsidiary of Tanabe Mitsubishi Pharma.
Mitsubishi Chemical G, Mitsui & Co., etc. [List of stock materials from the newspaper]
*Mitsubishi Chemical Group <4188> expands semiconductor materials for post-processing, suppressing sealing and thermal expansion (Nikkan Kogyo, front page) - ○ *Mitsui & Co. <8031> invests in U.S. synthetic fuels, eyeing decarbonization in the trucking industry (Nikkan Kogyo, page 4) - ○ *Kansai Electric Power <9503> reviews plans for the removal of spent nuclear fuel and presents them to Fukui Prefecture (Nikkan Kogyo, page 4) - ○ *Unitika <3103> receives 20 billion yen from REVIC and promotes structural reform (Nikkan Kogyo, page 4) - ○ *Miyoshi Oil & Fat <4404> announces new medium-term plan with capital investments of 20 billion yen.